Rakesh Popat graduated from Guy’s and St Thomas’ Medical School, London and trained in haematology at St Bartholomew’s Hospital. During this time, he completed a PhD thesis focusing on designing scientifically based treatment combinations for myeloma. This included pre-clinical work investigating novel combination treatments and developing them into early phase clinical studies. He was awarded a fellowship to visit the Dana Farber Cancer Institute in Boston, USA where he gained experience both in their drug-discovery laboratory and their clinical program.
He is a Consultant Haematologist and Senior Lecturer at University College Hospital, London where he leads the Phase 1 clinical trials program, bringing experimental myeloma treatments into the clinic. In addition, he is part of the leadership board of the UK Myeloma Research Alliance, the UK Myeloma Forum, and the North Thames Clinical Research Network lead for Haematology.